| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An infectious narrative
|
Burki, Talha Khan
|
|
2014
|
2 |
4 |
p. 266-
1 p.
|
article
|
| 2 |
Antibiotics for respiratory infections: too much, too soon
|
Burki, Talha Khan
|
|
2014
|
2 |
4 |
p. 262-
1 p.
|
article
|
| 3 |
Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study
|
Walker, Timothy M
|
|
2014
|
2 |
4 |
p. 285-292
8 p.
|
article
|
| 4 |
Child health and tuberculosis
|
Marais, Ben J
|
|
2014
|
2 |
4 |
p. 254-256
3 p.
|
article
|
| 5 |
Corrections
|
|
|
2014
|
2 |
4 |
p. e4-
1 p.
|
article
|
| 6 |
Corrections
|
|
|
2014
|
2 |
4 |
p. e4-
1 p.
|
article
|
| 7 |
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial
|
Raghu, Ganesh
|
|
2014
|
2 |
4 |
p. 277-284
8 p.
|
article
|
| 8 |
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
|
Dheda, Keertan
|
|
2014
|
2 |
4 |
p. 321-338
18 p.
|
article
|
| 9 |
MMR lowers infection-related hospital admissions in children
|
Tanday, Sanjay
|
|
2014
|
2 |
4 |
p. 263-
1 p.
|
article
|
| 10 |
Moving beyond “me-too” respiratory drugs
|
Furlow, Bryant
|
|
2014
|
2 |
4 |
p. 261-
1 p.
|
article
|
| 11 |
N-acetylcysteine for COPD: the evidence remains inconclusive
|
Turner, Richard D
|
|
2014
|
2 |
4 |
p. e3-
1 p.
|
article
|
| 12 |
N-acetylcysteine for COPD: the evidence remains inconclusive – Authors' reply
|
Zheng, Jin-Ping
|
|
2014
|
2 |
4 |
p. e3-e4
nvt p.
|
article
|
| 13 |
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
|
Jones, Rupert C M
|
|
2014
|
2 |
4 |
p. 267-276
10 p.
|
article
|
| 14 |
Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
|
Kaufmann, Stefan H E
|
|
2014
|
2 |
4 |
p. 301-320
20 p.
|
article
|
| 15 |
Pulmonary hypertension of sickle cell disease: new guidelines
|
Furlow, Bryant
|
|
2014
|
2 |
4 |
p. 263-
1 p.
|
article
|
| 16 |
Respiratory medicine and critical care: a call for papers
|
Godsland, Jane
|
|
2014
|
2 |
4 |
p. 260-
1 p.
|
article
|
| 17 |
Robert Heinrich Herman Koch
|
Akkermans, Rebecca
|
|
2014
|
2 |
4 |
p. 264-265
2 p.
|
article
|
| 18 |
Should we pursue pulmonary vasodilation in patients with COPD?
|
Brusselle, Guy
|
|
2014
|
2 |
4 |
p. 252-254
3 p.
|
article
|
| 19 |
Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial
|
Goudie, Andrew R
|
|
2014
|
2 |
4 |
p. 293-300
8 p.
|
article
|
| 20 |
The evolving role of advocacy in tuberculosis
|
DeLuca, Andrea
|
|
2014
|
2 |
4 |
p. 258-259
2 p.
|
article
|
| 21 |
The lung and winding road
|
The Lancet Respiratory Medicine,
|
|
2014
|
2 |
4 |
p. 247-
1 p.
|
article
|
| 22 |
Totally-drug-resistant tuberculosis: hype versus hope
|
Maeurer, Markus
|
|
2014
|
2 |
4 |
p. 256-257
2 p.
|
article
|
| 23 |
Towards earlier diagnosis of COPD
|
van Weel, Chris
|
|
2014
|
2 |
4 |
p. 248-249
2 p.
|
article
|
| 24 |
Tracking the history of influenza
|
van Dorn, Aaron
|
|
2014
|
2 |
4 |
p. 265-
1 p.
|
article
|
| 25 |
Understanding CT patterns in idiopathic pulmonary fibrosis
|
Hart, Simon P
|
|
2014
|
2 |
4 |
p. 249-250
2 p.
|
article
|
| 26 |
Use of interferon beta for acute respiratory distress syndrome: proceed with caution
|
George, Peter M
|
|
2014
|
2 |
4 |
p. e2-
1 p.
|
article
|
| 27 |
Use of interferon beta for acute respiratory distress syndrome: proceed with caution – Authors' reply
|
Bellingan, Geoff
|
|
2014
|
2 |
4 |
p. e2-e3
nvt p.
|
article
|
| 28 |
Whole-genome sequencing of Mycobacterium tuberculosis as an epidemiological marker
|
van Soolingen, Dick
|
|
2014
|
2 |
4 |
p. 251-252
2 p.
|
article
|
Journal description